As of the latest Form 4 filed Mar 19, 2026.
What Volitionrx Ltd insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 20 most recent filings for VNRX.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-17-05:00 | Forterre Gael Chief Commercial Officer | FTax | −5.25K | $0.19 | $997.69 | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-17-05:00 | Rootsaert Rodney Gerard Secretary | FTax | −3.95K | $0.19 | $750.12 | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-17-05:00 | Plummer Nicholas GC - Volition Diagnostics | FTax | −7.00K | $0.19 | $1.33K | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-17-05:00 | Micallef Jacob Vincent Chief Scientific Officer | FTax | −5.31K | $0.19 | $1.01K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Rubin Ethel Director | AAward | +12.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Innes Guy Archibald Director | AAward | +12.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Forterre Gael Chief Commercial Officer | AAward | +38.1K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Reynolds Cameron John President and CEO | AAward | +74.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Colman Alan Director | AAward | +12.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | STILL TIMOTHY I Director | AAward | +90.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Batchelor Ann-Louise Group Chief Marketing Officer | AAward | +33.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Hughes Terig Chief Financial Officer | AAward | +49.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Barnes Phillip Director | AAward | +12.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Butera Salvatore Thomas CEO - Volition Veterinary | AAward | +53.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Rootsaert Rodney Gerard Secretary | AAward | +28.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Micallef Jacob Vincent Chief Scientific Officer | AAward | +35.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Plummer Nicholas GC - Volition Diagnostics | AAward | +44.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Henshall Mickie Director | AAward | +12.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Nguyen Kim Director | AAward | +12.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-22-05:00 | Kway Jasmine CEO - Singapore Volition | AAward | +42.0K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also VNRX’s full analysis or the market-wide insider trading feed. The tabs above jump to VNRX’s other SEC data.
Source: SEC Form 4 filings for VNRX, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.